O texto abaixo foi recebido por e-mail do Informativo CEDOC N. 83, 2010 / Newsletter CEDOC N. 83, 2010
Também disponível no Site de PANAFTOSA - http://new.paho.org/panaftosa/index.php?option=com_content&task=view&id=52&Itemid=246
Temas de interés general / Subjects of general interest
The History of Vaccines is an informational, educational website created by The College of Physicians of Philadelphia .
The site aims to increase public knowledge and understanding of the ways in which vaccines, toxoids, and passive immunization work, how they have been developed, and the role they have played in the improvement of human health.
http://www.historyofvaccines.org
Informaciones disponibles en formato electrónico / Information available in electronic format
Economia, Ganaderia/ Economy, Livestock
1. Animal diseases and the cost of compliance with international standards and export markets. The Experience of Foot-and-Mouth Diseasein the Southern Cone World Bank (Agriculture and Rural Development Discussion Papers)
Rich KM
By their nature, animal disease outbreaks present significant costs and risks to affected countries. For countries that depend on livestock exports as a source of revenue, the discovery of an animal disease will result in the immediate, albeit temporary, closure of export markets, and impose significant costs on other sectors of the economy (for example, tourism, downstream industries related to livestock). Foot-andmouth disease (FMD) is particularly damaging due to its rapid spread and effects on livestock productivity. Because of this, countries that have eradicated FMD impose strict sanitary restrictions on meat imports, creating a segmented market in which FMD-free products sell at a price premium over non-FMD-free products. Furthermore, given the difficulty in distinguishing between meat from vaccinatedanimals and those that have generated an immune response, the international beef market is further segmented into FMD-free with and without vaccination components.
The experience of countries in the Southern Cone demonstrated that the control of FMD requires institutional machinery in both the public and private sectors that none of the three countries possessed at the time of the 2000–01 outbreak. The crisis also showed the limits of public monitoring and surveillance, and the need for transparent, independent risk assessment at a regional level. While there is no clear answer as to whether public or private approaches for recovery from FMD are optimal, successful control of and recovery from FMD requires significant coordination among all actors in the animal health and livestock sectors. At the same time, it should be stressed that sustainable FMD control requires coordination among countries throughout the whole of South America. The coexistence of regions that were not vaccinating in the late 1990s (Argentina, parts of Brazil, Paraguay, and Uruguay) alongside those in which FMD was endemic (Bolivia, Colombia, Ecuador, and Peru) suggested that it was only a matter of time before FMD would reappear in the Southern Cone. This reality might suggest a role for the Southern Cone to assist in financing FMD control and market development efforts in Bolivia, Colombia, Ecuador, Paraguay, and Peru. Joint collaborative efforts across regions will be required, including regional surveillance, monitoring programs, and information sharing across borders. However, funding, 2 institutional mechanisms, and roles for the public and private sectors for such collaboration need to be thoroughly addressed in tandem with such efforts.
Text in English
http://vle.worldbank.org/bnpp/files/TF051844REGIONALGLOBALFMDMercosurF.pdf
2. Consequências positivas das barreiras não-tarifárias no comércio internacional de produtos do agronegócio: o caso da cadeia da carne bovina
Andrade RPL
Tese (Doutorado) - Universidade Federal Rural do Rio de Janeiro; 2007
The proposal of the thesis was to identify and analyze the most important positive consequences, stemming from the efforts of brazilian export companies of products related to agribusiness, to overcome the non-tariff barriers imposed by the companies and / or importing countries. These consequences are little explored in discussions and can be considered as external to the process of implementation of non-tariff barriers. In order to make the proposed work would be feasible, the chain's beef was elected as a target of further studies, the fact that an item be expressive of the Tariff Brazilian export, and because the wide variety of norms, standards and regulations of these products, widespread in all the links of its production chain.
The results point to the need to create instruments of Brazil institutional and technical competence in order to administer and live in the best way possible with the inexorable increase in the presence of technical barriers to trade in agricultural products. Finally, although not always be possible to establish a direct relationship of cause and effect, the study developed to say that there is a close correlation between the movements in the interests of overcoming the technical barriers in world trade in products of agribusiness, and the benefits to Brazilian society as a whole. Benefits have been identified related to: technological development, the environment, improvement of legislation, aggregation of trade blocs, managerial innovation, reduce competition, maintain competitive advantage and labor relations. In this context, the chain of meat proved a good example for the hypothesis raised, because all segments studied showed, albeit in different degrees, the conversion of the require ents of international buyers in benefits for the internal market and for the Brazilians in general.
Text in Portuguese
http://www.ufrrj.br/cpda/static/tese_rafael_de_andrade.pdf
3. The effect of foot and mouth disease on trade and prices in international beef markets
Jarvis LS, Canicino JP, Bervejillo JE
American Agricultural Economics Association Annual Meeting, 2005
The paper develops and uses a two step quantitative model to analyze the effect of Foot and Mouth Disease (FMD) on international beef markets over time. Using monthly data from 1990-2002 for 7 major beef exporters and for 22 major beef importers, we use a probit equation to estimate the probability that country i exports to country j, taking account of foot and mouth status of exporter, sanitary policy of importer, beef quality, trade preferences, distance, and other factors affecting whether beef trade occurs. We then use OLS to estimate the export prices that are obtained for beef, taking account of beef quality, country per capita, trading preferences, region, per capita income, and a time trend, including terms to adjust for censorship in the first stage. Using the estimated equations, we compare the predicted change in trading partners and in the prices received by the two exporters in our sample that are not FMD free, Brazil and Uruguay, under the assumption that their status switches from having FMD to being FMD free. The model performs well. The results suggest that FMD continues to impede trade between many countries and does accordingly reduce the price received for beef from countries with FMD. Nonetheless, the "sanction" from FMD appears smaller than previously believed.
Text in English
http://ageconsearch.umn.edu/bitstream/19424/1/sp05ja05.pdf
4. Guidelines on the use of economic analysis to inform SPS‐related decision‐making
Henson S, Masakure O
November 2009
This report reviews experiences with the use of economic analysis to guide priority-setting for sanitary and phytosanitary (SPS) capacity building in developing countries, highlights the challenges faced in using such methods and provides general guidance to decision-makers on which economic analysis approaches are best suited to particular decision scenarios. In preparing the report the existing literature has been reviewed and practitioners of economic analysis consulted on their experiences. A framework is proposed for establishing priorities between SPS capacity building options across the broad areas of food safety, animal health and plant health that can take account of varied and multiple decision criteria.
Text in English
http://www.standardsfacility.org/files/EconomicAnalysis/STDF_Coord_291_Guidelines_22Jan10.pdf
Fiebre Aftosa / Foot and Mouth Disease
5. Expression of the major epitope regions of 2C integrated with the 3AB non-structural protein of foot-and-mouth disease virus and its potential for differentiating infected from vaccinated animals
Lu Z, Zhang X, Fu Y, Cao Y , Tian M, Sun P, Li D, Liu Z, Xie Q
J Virol Methods. 2010 Sep
In recent years, the potential value of the non-structural proteins (NSP) 2C and 3ABC has been well documented for differentiation of animals infected with foot-and-mouth disease virus (FMDV) from vaccinated animals (DIVA). In order to develop a more sensitive approach to detect animals infected naturally in herds of FMDV-vaccinated animals, a 47.6kD fusion protein named 2C3AB was expressed in bacteria which incorporated two major B-cell epitope regions of 2C and the whole 3AB within the NSP of FMDV. The product reacted specifically with sera from animals infected with FMDV, but did not react with sera from non-vaccinated and healthy animals. The performance of 2C3AB was compared further with the 3ABC fusion protein as the antigen in an indirect ELISA format for DIVA. The results showed that the 2C3AB-ELISA had an even stronger signal reaction in the indirect ELISA and showed higher sensitivity than the 3ABC-ELISA for DIVA purposes and for detection of early virus infection in animals. Therefore, it is expected that the recombinant protein 2C3AB could be a good candidate protein with which to develop more sensitive methods for DIVA and for surveillance of herds infected subclinically under conditions of vaccination. This study indicates that the 2C3AB-ELISA can be used to confirm the results of the 3ABC-ELISA to improve the performance of the 3ABC-ELISA DIVA test.
Text in English (article in press)
6. Fighting foot-and-mouth disease together
Global Foot-and-Mouth Disease Research Alliance (GFRA)
The Global Foot-and-Mouth Disease Research Alliance (GFRA): A worldwide association of animal health research organizations to assist the global control and eventual eradication of foot-and-mouth disease.
Text in English
http://www.ars.usda.gov/gfra/files/GFRA%20brochure.pdf
7.Meta-analysis on the efficacy of foot-and-mouth disease emergency vaccination
Halasa T, Boklund A, Cox S, Enøe C
Prev Vet Med. 2010 Sep
Text in English (article in press)
8. Procedimento para análise de decisão quanto à prevenção de doenças em animais: uma aplicacão da Teoria dos Jogos [Procedure for decision analysis on prevention against animal diseases: an application of Game Theory]
Silveira LT
Tese (Doutorado) – Universidade de São Paulo. Escola Superior de Agricultura “Luiz de Queiroz”; 2008
Text in Portuguese
http://www.teses.usp.br/teses/disponiveis/11/11132/tde-22072008-163512/pt-br.php
Influenza Aviar / Avian Influenza
9.Avaliação do impacto econômico de possíveis surtos da gripe aviária no Brasil: uma análise de equilíbrio geral computável [The economic impact of potential avian flu outbreaks in Brazil: a general equilibrium model analysis]
Fachinello AL
Tese (Doutorado) – Universidade de São Paulo. Escola Superior de Agricultura “Luiz de Queiroz”; 2008
Text in Portuguese
http://www.teses.usp.br/teses/disponiveis/11/11132/tde-17072008-150109/pt-br.php
10.Epidemiologia e caracterização molecular de vírus da Influenza em aves residentes e migratórias no Brasil [Epidemiology and molecular characterization of Influenza virus in migratory and resident birds in Brazil]
Golono Ma
Tese (Doutorado) - Universidade de São Paulo. Instituto de Ciências Biomédicas; 2009
The avian influenza virus has caused epidemics and pandemics through the ages, the most devastating pandemic that we know, the Spanish flu in 1918, had its origin in the avian virus type A subtype H1N1. Since 2003 the avian virus subtype H5N1 has infected 442 people and led to death 262. Besides the health aspect of the avian influenza viruses cause major economic impact. Brazil as the largest exporter of chicken in the world has much to lose if bird flu reaches the country. Because wild birds are the natural reservoir of influenza A, is that it is necessary to implement the monitoring. Although programs exist for continuous monitoring of wild birds in Europe, USA, Canada, Japan and others, little has been done in Brazil. Samples collected from 671 birds were tested by GeneScan techniques, real-time PCR and RT-PCR and nested-PCR Duplex.
Text in Portuguese
http://www.teses.usp.br/teses/disponiveis/87/87131/tde-11022010-104048/pt-br.php
11. Risk mapping for avian influenza: a social–ecological problem
Cumming GS
Ecology and Society 2010; 15 (3)
Text in English
http://www.ecologyandsociety.org/issues/view.php?sf=39
Malaria
12. Effectiveness of five artemisinin combination regimens with or without primaquine in uncomplicated falciparum malaria: an open-label randomised trial
Smithuis F, Kyaw MK, Phe O, Win T, Aung PP, Oo AP, Naing AL, Nyo MY, Myint NZ, Imwong M, Ashley E, Lee SJ, White NJ
Lancet Infect Dis. 2010 Oct; 10 (10): 673-81
BACKGROUND: Artemisinin-combination therapy (ACT) is recommended as first-line treatment of falciparum malaria throughout the world, and fixed-dose combinations are preferred by WHO; whether a single gametocytocidal dose of primaquine should be added is unknown. We aimed to compare effectiveness of four fixed-dose ACTs and a loose tablet combination of artesunate and mefloquine, and assess the addition of a single gametocytocidal dose of primaquine.
METHODS: In an open-label randomised trial in clinics in Rakhine state, Kachin state, and Shan state in Myanmar (Burma) between Dec 30, 2008, and March 20, 2009, we compared the effectiveness of all four WHO-recommended fixed-dose ACTs (artesunate-mefloquine, artesunate-amodiaquine, dihydroartemisinin-piperaquine, artemether-lumefantrine) and loose artesunate-mefloquine in Burmese adults and children. Eligible patients were those who presented to the clinics with acute uncomplicated Plasmodium falciparum malaria or mixed infection, who were older than 6 months, and who weighed more than 5 kg . Treatments were randomised in equal numbers within blocks of 50 and allocation was in sealed envelopes. All patients were also randomly assigned to receive either a single dose of primaquine 0·75 mg base/kg or not. Patients were followed up for 63 days. Treatment groups were compared by analysis of variance and multiple logistic regression. The primary outcome was the 63 day recrudescence rate. This study is registered with clinicaltrials.gov, number NCT00902811.
FINDINGS: 155 patients received artesunate-amodiaquine, 162 artemether-lumefantrine, 169 artesunate-mefloquine, 161 loose artesunate-mefloquine, and 161 dihydroartemisinin-piperaquine. By day 63 of follow-up, 14 patients (9·4%; 95% CI 5·7-15·3%) on artesunate-amodiaquine had recrudescent P falciparum infections, a rate significantly higher than for artemether-lumefantrine (two patients; 1·4%; 0·3-5·3; p=0·0013), fixed-dose artesunate-mefloquine (0 patients; 0-2·3; p<0·0001), loose artesunate-mefloquine (two patients; 1·3%; 0·3-5·3; p=0·0018), and dihydroartemisinin-piperaquine (two patients 1·3%; 0·3-5·2%; p=0·0012). Hazard ratios for re-infection (95% CI) after artesunate-amodiaquine were 3·2 (1·3-8·0) compared with the two artesunate-mefloquine groups (p=0·01), 2·6 (1·0-6-0) compared with artemether-lumefantrine (p=0·04), and 2·3 (0·9-6·0) compared with dihydroartemisinin-piperaquine (p=0·08). Mixed falciparum and vivax infections were common: 129 (16%) had a mixed infection at presentation and 330 (41%) patients had one or more episodes of Plasmodium vivax infection during follow-up. The addition of a single dose of primaquine (0·75 mg/kg) reduced P falciparum gametocyte carriage substantially: rate ratio 11·9 (95% CI 7·4-20·5). All regimens were well tolerated. Adverse events were reported by 599 patients, most commonly vomiting and dizziness. Other side-effects were less common and were not related to a specific treatment.
INTERPRETATION: Artesunate-amodiaquine should not be used in Myanmar, because the other ACTs are substantially more effective. Artesunate-mefloquine provided the greatest post-treatment suppression of malaria. Adding a single dose of primaquine would substantially reduce transmission potential. Vivax malaria, not recurrent falciparum malaria, is the main complication after treatment of P falciparum infections in this region.
FUNDING: Médecins sans Frontières (Holland) and the Wellcome Trust Mahidol University Oxford Tropical Medicine Research Programme.
Text in English
http://download.thelancet.com/pdfs/journals/laninf/PIIS1473309910701870.pdf?id=e16241398b8eb460:7c9b863:12b9c191a1f:-2dd41286817088650
13. Maximising the public health benefit of antimalarials
Price RN, Douglas NM
Lancet Infect Dis. 2010 Oct; 10 (10): 654-5
Artemisinin combination therapies (ACTs) are integral to current malaria treatment strategies. They effect rapid and complete clearance of multidrug-resistant strains of Plasmodium spp, decrease the transmission potential of the parasite, and limit the emergence of de novo resistance.
Text in English
http://download.thelancet.com/pdfs/journals/laninf/PIIS1473309910701924.pdf?id=e16241398b8eb460:7c9b863:12b9c191a1f:-2dd41286817088650
One Health
Zinsstag J, Schelling E, Waltner-Toews D, Tanner M
Prev Vet Med. 2010 Sep
Faced with complex patterns of global change, the inextricable interconnection of humans, pet animals, livestock and wildlife and their social and ecological environment is evident and requires integrated approaches to human and animal health and their respective social and environmental contexts. The history of integrative thinking of human and animal health is briefly reviewed from early historical times, to the foundation of universities in Europe, up to the beginning of comparative medicine at the end of the 19th century. In the 20th century, Calvin Schwabe coined the concept of "one medicine". It recognises that there is no difference of paradigm between human and veterinary medicine and both disciplines can contribute to the development of each other. Considering a broader approach to health and well-being of societies, the original concept of "one medicine" was extended to "one health" through practical implementations and careful validations in different settings. Given the global health thinking in recent decades, ecosystem approaches to health have emerged. Based on complex ecological thinking that goes beyond humans and animals, these approaches consider inextricable linkages between ecosystems and health, known as "ecosystem health". Despite these integrative conceptual and methodological developments, large portions of human and animal health thinking and actions still remain in separate disciplinary silos. Evidence for added value of a coherent application of "one health" compared to separated sectorial thinking is, however, now growing. Integrative thinking is increasingly being considered in academic curricula, clinical practice, ministries of health and livestock/agriculture and international organizations. Challenges remain, focusing around key questions such as how does "one health" evolve and what are the elements of a modern theory of health? The close interdependence of humans and animals in their social and ecological context relates to the concept of "human-environmental systems", also called "social-ecological systems". The theory and practice of understanding and managing human activities in the context of social-ecological systems has been well-developed by members of The Resilience Alliance and was used extensively in the Millennium Ecosystem Assessment, including its work on human well-being outcomes. This in turn entails systems theory applied to human and animal health. Examples of successful systems approaches to public health show unexpected results. Analogous to "systems biology" which focuses mostly on the interplay of proteins and molecules at a sub-cellular level, a systemic approach to health in social-ecological systems (HSES) is an inter- and trans-disciplinary study of complex interactions in all health-related fields. HSES moves beyond "one health" and "eco-health", expecting to identify emerging properties and determinants of health that may arise from a systemic view ranging across scales from molecules to the ecological and socio-cultural context, as well from the comparison with different disease endemicities and health systems structures.
Text in English (article in press)
14. One Health - attaining optimal health for people, animals, and the environment
Atlas R, Rubin C, Maloy S, Daszak P, Colwell R, Hyde B
Microbe 2010 Sep, 5 (9): 383-9
The interdependence of humans, animals, and their environment has never been more important than now. The most prominent issues putting pressure on global health today include the dramatic emergence and spread of zoonotic diseases, contamination of food, water and soil, bioterrorist events, and degradation of resources and habitats. Current global health challenges have prompted a call for more holistic, collaborative, action-oriented approaches toward the goal of logical and practical solutions. Veterinarians have pivotal obligations, opportunities, and contributions to make in enhancing public health, recognising and responding to zoonotic disease transmission, maintaining food and water quality, and promoting wildlife and ecosystem health.
Text in English
http://www.oie.int/boutique/extrait/04osburn481486.pdf
15. One Health Newsletter
2010, Volume 3 Issue 3
This newsletter is dedicated to enhancing the integration of animal, human, and environmental health for the benefit of all by demonstrating One Health in practice.
Text in English
http://www.doh.state.fl.us/Environment/medicine/One_Health/OHNLSummer2010.pdf
16. Understanding risk perceptions to enhance communication about human-wildlife interactions and the impacts of zoonotic disease
Decker DJ, Evensen DTN, Siemer WF, Leong KM, Riley SJ, Wild MA, Castle KE, Higgins CL
ILAR Journal 2010; 51 (3): 255-61
Inclusion of wildlife in the concept of One Health is important for two primary reasons: (1) the physical health of humans, domesticated animals, and wildlife is linked inextricably through shared diseases, and (2) humans’ emotional well-being can be affected by their perceptions of animal health. Although an explicit premise of the One Health Initiative is that healthy wildlife contribute to human health, and vice versa, the initiative also suggests implicitly that wildlife may pose threats to human health through zoonotic disease transmission. As people learn more about One Health, an important question surfaces: How will they react to communications carrying the message that human health and wildlife health are linked? In the absence of adequate relevant research data, we recommend caution in the production and dissemination of One Health messages because of possible unintended or collateral effects. Understanding how and why individuals perceive risks related to wildlife diseases is essential for determining message content that promotes public support for healthy wildlife populations, on the one hand, and, on the other, for identifying messages that might inadvertently increase concern about human health effects of diseased wildlife. To that end, we review risk perception research and summarize the few empirical studies that exist on perceived risk associated with zoonoses. We conclude with some research questions that need answering to help One Health practitioners better understand how the public will interpret their messages and thus how to communicate positively and without negative collateral consequences for wildlife conservation.
Text in English
Rabia / Rabies
17.Avaliação do Vampiricida Gel 1% no controle seletivo direto de colônias de Desmodus rotundus [Evaluation of 1-percent Vampiriced Gel in direc selective control of Desmodus rotundus colonies]
Pompei JCA
Dissertação (Mestrado) - Universidade Federal Rural do Rio de Janeiro. Instituto de Veterinária; 2009
The National Program on Control of Herbivore Rabies (PNCRH) concentrates its actions on population control of the diseases main transmitter, the vampire bat of the Desmodus rotundus species, and favors the use of direct and indirect selective methods. This study sought to evaluate the effectiveness of the VAMPIRICID GEL for direct selective control of D. rotundus colonies. Six daytime shelters were selected; in each one a count was taken of the live individuals at the time and then again ten days after treatment. Two shelters per treatment Group were addressed. The Vampiricid Gel was applied on the back of vampire bats in 5-percent (Group 1) and of 10-percent (Group 2) samples of the population. For control (Group 3), 10 percent of the D. rotundus bat population was treated with liquid Vaseline. An evaluation was also made of the aggressions by vampire bats on 3,690 bovines and 133 equids on the 22 properties located within a 3-km radius of the shelters. Fishers Exact and χ2 tests were used with a 1-percent significance level. Under natural conditions, treatment of Groups 1, 2, and 3 reduced by 97.57 percent, 99.30 percent, and 3.6 percent, respectively, the D. rotundus population, and by 92.79 percent, 94.36 percent, and 4.76 percent, respectively, the number of animals attacked, ten days after treatment. Results have shown that the 1-percent VAMPIRICID GEL was effective in significantly reducing the bat population and the number of animals attacked in Groups 1 and 2, as compared with Group 3. There was no significant different between Groups 1 and 2 as regards both reduction of the D. rotundus population and the number of animals attacked. Although the use of 1-percent VAMPIRICID GEL on 5 percent or 10 percent of the vampire bat population has yielded similar results in the D. rotundus populations in the shelters and thus on attacked bovines and equids, its use on 5 percent of the populations was more effective, given the lower operating cost, and can thus be indicated for direct selective control of D. rotundus.
Text in Portuguese
http://bdtd.ufrrj.br//tde_busca/arquivo.php?codArquivo=1295
18.Newsletter of the Alliance for Rabies Control
Nº 19, September 2010
This month the world will observe the fourth annual World Rabies Day.
There are many conferences relevant to rabies control that are scheduled to take place in the upcoming months and you will find more informaon on these meengs enclosed in the Newsleter.
Text in English
http://www.rabiescontrol.net/ARCnewsletter19.pdf
19.Reducing the global burden of rabies
Briggs DJ
International Health 2010; 2: 161–162
September 28, 2010 marks the fourth observation of World Rabies Day. This annual event continues to provide a unique platform for individuals, countries and international organizations to highlight educational awareness in their own regions and provides an opportunity to focus on the implementation of national rabies prevention and control programs.
Ultimately, the best solution to prevent human rabies is to implement effective regional rabies control programs through partnerships between a wide variety of organizations and ministries including those focused on animal and human health, education, animal welfare, communications and finance. Successes in the elimination of canine rabies from some areas are proof that rabies serves as a model disease to institute a one health approach to prevention and control. World Rabies Day continues to serve as a focal point for individuals and global organizations working to promote rabies prevention activities and save lives across the globe.
Text in English
http://www.rabiescontrol.net/assets/files/Scientific%20Literature%20pdfs/Reducing%20burden.pdf
Tuberculosis Bovina / Bovine Tuberculosis
20. La Tuberculosis Bovina en Venezuela: patogénesis, epidemiología, respuesta inmunitaria y nuevas alternativas para el diagnóstico
Rivera S, Giménez JF
REDVET 2010 Sep; 11 (9)
La tuberculosis bovina, enfermedad infectocontagiosa causada por Mycobacterium bovis, se encuentra difundida por el mundo entero, es un problema de salud pública (Zoonosis), debido a que el M. bovis puede infectar al hombre produciendo un cuadro de tuberculosis clínicamente indistinguible al causado por M. tuberculosis, el cual es causa de la tuberculosis humana. M. bovis, es un patógeno intracelular que infecta las células del sistema inmune del hospedador principalmente macrófagos, una vez dentro del macrófago la mycobacteria puede ser destruida por los diferentes mecanismos microbicidas que éste posee o sobrevivir y utilizar al macrófago para multiplicarse y viajar dentro de este y ganar acceso a otros tejidos por medio de la circulación sanguínea o linfática. El Diagnóstico de la enfermedad luce bastante complicado a la luz de las nuevas técnicas de evaluación de la respuesta inmunitaria que complementan la clásica tuberculinización y el cultivo bacteriológico. Venezuela ha experimentado un incremento de la prevalencia 60 de cada 10.000 animales están infectados. El uso de las recién desarrolladas pruebas del INF-γ, ELISA-TBC y PCR, en zonas de alta prevalencia, ha permitido mostrar diferentes patrones de respuesta inmunitaria frente a M. bovis y dar un nuevo enfoque a los estudios epidemiológicos de la enfermedad.
Text in English
http://www.veterinaria.org/revistas/redvet/n090910/091007.pdf
Zoonosis / Zoonoses
21.Vigilância em saúde: zoonoses
Brasil. Ministério da Saúde. Secretaria de Atenção à Saúde. Departamento de Atenção Básica
2009
Publicação de 2009 do Ministério da Saúde com extensas informações para profissionais da saúde sobre diversos aspectos de algumas das zoonoses que ocorrem no país.
Text in Portuguese
http://bvsms.saude.gov.br/bvs/publicacoes/vigilancia_saude_zoonoses_p1.pdf
I really appreciate it.
ResponderExcluir